SUY1V Suominen OYJ

Suominen introduces novel material FIBRELLA® Shield for face mask applications

Suominen introduces novel material FIBRELLA® Shield for face mask applications

Suominen Corporation’s press release on June 17, 2020 at 2:00 p.m. (EEST)

Suominen has developed a nonwoven material for the manufacturing of face mask applications. The new nonwoven has passed European Standard EN 14683:2019 Type II requirements in terms of filtration efficiency and pressure drop.

“Our FIBRELLA® Shield nonwoven has excellent filtration efficiency and pressure drop values meaning that the material provides protection while being comfortable and easy to breathe through. Measured with an applied method by VTT* results indicate that FIBRELLA® Shield nonwoven’s filtration efficiency is higher than 99% reaching type II requirements but of course the material can also be used for lighter model Type I masks or uncertified masks,” says Category Manager Johanna Sirén.

“FIBRELLA® Shield has received positive feedback from several user panel tests about its textile-like softness and being odorless. The panel results show also that FIBRELLA® Shield is comfortable to use even for several hours and it doesn’t build up moisture during use,” Johanna Sirén continues.

The standard EN14683:2019 for medical masks is for end products and the converter has to repeat the tests to confirm the standard compliancy for the end product. The end product needs to comply also with the regional regulations, if any.

Developed in cooperation with VTT, this new material is the latest addition to the FIBRELLA® family. FIBRELLA® Shield is already in production at Suominen’s Nakkila plant. Currently the plant is capable of producing material for approximately 15 million masks per month.

SUOMINEN CORPORATION

For more information, please contact

Johanna Sirén, Category Manager, tel. +358 50 520 5360,

Customer inquiries

Aleksandra Rakoczy-Frankowska,

 

Suominen manufactures nonwovens as roll goods for wipes and other applications. Our vision is to be the frontrunner for nonwovens innovation and sustainability. The end products made of Suominen’s nonwovens, such as wet wipes, feminine care products and swabs, are present in people’s daily life worldwide. Suominen’s net sales in 2019 were EUR 411.4 million and we have nearly 700 professionals working in Europe and in the Americas. Suominen’s shares are listed on Nasdaq Helsinki. Read more at

*VTT Technical Research Centre of Finland report VTT-CR-00403-20 (in Finnish) 

Attachment

EN
17/06/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Suominen OYJ

 PRESS RELEASE

Suominen Corporation – Manager’s transaction: Charles Héaulmé

Suominen Corporation – Manager’s transaction: Charles Héaulmé Suominen Corporation February 2, 2026 at 10:00 a.m. (EET) Charles Héaulmé has reported to have made transactions with Suominen Corporation's shares. The transactions are presented below as a summary, and in detail as per the disclosure requirement. Acquisitions on January 29, 2026: Total amount 10 000 sharesVolume weighted average price EUR 1.6700 Suominen Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Charles HéaulméPosition: Chief Executive Officer...

 PRESS RELEASE

Suominen Oyj – Johtohenkilön liiketoimet: Charles Héaulmé

Suominen Oyj – Johtohenkilön liiketoimet: Charles Héaulmé Suominen Oyj 2.2.2026 klo 10.00 Charles Héaulmé on ilmoittanut tehneensä Suomisen osakkeilla liiketoimia, joista alla yhteenveto sekä tiedotusvelvollisuuden mukaiset yksilöintitiedot.Hankinnat 29.1.2026: Kokonaismäärä 10 000 osakettaKaupankäyntimäärillä painotettu keskihinta 1,6700 euroa Suominen Oyj - Johdon liiketoimet____________________________________________IlmoitusvelvollinenNimi: Charles HéaulméAsema: ToimitusjohtajaLiikkeeseenlaskija: Suominen OyjLEI: 743700Z1BNFYR9PRDF52Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero...

 PRESS RELEASE

Inside information: Suominen launches three-year profitability improve...

Inside information: Suominen launches three-year profitability improvement program and introduces new operating model and leadership team Suominen Corporation's inside information on January 29, 2026, at 9:45 a.m. (EET) Suominen is launching a three-year program to improve the company’s profitability. The Full Potential Program targets 10% EBITDA by 2028. Suominen is also introducing a new functional operating model, with a dedicated focus on customers and factories, designed to strengthen expertise and effectiveness.  Suominen is undertaking an ambitious transformation to unlock the comp...

 PRESS RELEASE

Sisäpiiritieto: Suominen käynnistää kolmivuotisen kannattavuuden paran...

Sisäpiiritieto: Suominen käynnistää kolmivuotisen kannattavuuden parantamisohjelman, uudistaa toimintamallinsa ja johtoryhmän Suominen Oyj:n sisäpiiritieto 29.1.2026 klo 9.45 Suominen käynnistää kolmivuotisen ohjelman yhtiön kannattavuuden parantamiseksi. Full Potential -ohjelman tavoitteena on saavuttaa 10 %:n käyttökate (EBITDA) vuoteen 2028 mennessä. Lisäksi Suominen ottaa käyttöön uuden, funktionaalisen toimintamallin. Asiakas- ja tehdaslähtöisen toimintamallin tavoitteena on vahvistaa osaamista ja tehokkuutta. Suominen aloittaa kunnianhimoisen muutosohjelman, jonka tavoitteena on saa...

 PRESS RELEASE

Commencement of a new plan period in the share-based Long-Term Incenti...

Commencement of a new plan period in the share-based Long-Term Incentive Plan for management and key employees Suominen Corporation's stock exchange release on January 29, 2026 at 9:35 a.m. (EET)                 New Performance Period 2026–2028 Based on the existing share-based Long Term Incentive Plan for management and key employees, communicated as a stock exchange release on February 6, 2024, the Board of Directors of Suominen Corporation has decided on the commencement of a new plan period covering the years 2026–2028. The purpose of the plan is to align the interests of the company...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch